What amount sold does MBQ PHARMA INC. report in Form D filings?

The latest linked filings report $4.2M sold across 5 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was MBQ PHARMA INC.'s most recent SEC filing?

MBQ PHARMA INC.'s most recent Form D filing was on 2026-08-14.

How many investors does MBQ PHARMA INC. have?

The most recent Form D filing lists 8 investor(s).

What type of securities does MBQ PHARMA INC. offer?

MBQ PHARMA INC.'s SEC Form D filings indicate equity offerings.

MBQ PHARMA INC.

CIK: 0002148840·Pharmaceuticals·SAN JUAN, PR·Corporation

Reported Sold

$4,228,038

Total Filings

Identified Offerings

Last Filed

Aug 14, 2026

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Pharmaceuticals industry

SEC EDGAR

Offering filing timeline

Aug 14, 2026Form D — New notice

Reported sold: $1,530,000 · Target: Indefinite

Rule 506(b)·8 investors

Aug 14, 2026Form D — New notice

Reported sold: $882,000 · Target: $882,000

Rule 506(b)·3 investors

Aug 14, 2026Form D — New notice

Reported sold: $325,000 · Target: $325,000

Rule 506(b)·3 investors

Aug 14, 2026Form D — New notice

Reported sold: $500,000 · Target: $500,000

Rule 506(b)·2 investors

Aug 14, 2026Form D — New notice

Reported sold: $991,038 · Target: Indefinite

Rule 506(b)·8 investors

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

Revenue Range

Decline to Disclose

Reported commissions across identified offerings

Amendment Rate

Latest reported sold across 5 identified offerings

$4,228,038

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Filing History

Date	Type	Offering target	Reported sold	Investors
Aug 14, 2026	New	Indefinite	$1,530,000	8
Aug 14, 2026	New	$882,000	$882,000	3
Aug 14, 2026	New	$325,000	$325,000	3
Aug 14, 2026	New	$500,000	$500,000	2
Aug 14, 2026	New	Indefinite	$991,038	8

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

Telemachus Therapeutics, Inc.

Pharmaceuticals

Offering target: $1,500,000

Filed Oct 28, 2026